2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Advance Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee

Research Snapshot Theater: Resuscitation, Adult II

Hemodynamic Impact of Albumin Timing Post-Initial Fluid  Resuscitation in Septic Shock

Monday, March 23, 2026
10:15 AM - 11:15 AM Central Time
Location: Connections Central - RST 17
Introduction: Available literature suggests albumin resuscitation in septic shock (SS) may reduce vasopressor requirements and cumulative fluid balance, but albumin timing varies. The purpose of this study was to assess optimal timing of albumin within 72 hours of initial SS crystalloid resuscitation.


Methods: This retrospective study included SS patients that received guideline-recommended 30 mL/kg of crystalloid resuscitation. The primary objective was to assess the impact of albumin timing on vasopressor alive-and-free days. Secondary endpoints included vasopressor-free days, time to shock resolution, shock recurrence, need for new renal replacement therapy, ICU length of stay, hospital length of stay, and 28-day mortality.


Results: Of patients included, 59 received albumin within 72 hours after initial crystalloid resuscitation, while 27 patients did not. Patients received a median of 31.9 mL/kg of initial crystalloid resuscitation that consisted mostly of lactated ringers (54.7%). For patients that received albumin, the median initial dose was 25 g at a concentration of 5% (79.7%). When albumin and no albumin groups were compared, results found no difference in vasopressor alive-and-free days, time to shock resolution, ICU and hospital length of stay (LOS), and 28-day mortality. However, there were significant differences in shock recurrence (13.6% vs 44.4%) and new renal replacement therapy (10.2% vs 0.0%). When albumin is given for SS, optimal timing was found to be 8.75 to 72 hours after initial crystalloid resuscitation for a perceived 6.92 day improvement in vasopressor alive-and-free days compared to those outside the perceived optimal timing.


Conclusions: Patients that received albumin within 72 hours of initial SS crystalloid resuscitation had similar vasopressor alive-and-free days with reduced shock recurrence when compared to patients that did not receive albumin. Findings suggest optimal timing for albumin may be 8.75 to 72 hours after crystalloid resuscitation warranting further investigation.